Study of the Safety, Tolerability, Pharmacokinetics and Pharmcodynamics of ILV-094 in Healthy Subjects
NCT00447681
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
ILV-094
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer